Global Active Collagen Peptide Market Growth 2025-2031--LP INFORMATION, INC.

Global Active Collagen Peptide Market Growth 2025-2031

Product Code: 1687861

Industry: Medical Care

Published: Jun 28,2025

Pages: 94

Delivery Time: 2-3 business days

Global Active Collagen Peptide Market Growth 2025-2031

Product Code: 1687861

Industry: Medical Care

Published: Jun 28,2025

Pages: 94

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Active Collagen Peptide market size is predicted to grow from US$ 691 million in 2025 to US$ 1102 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Active collagen peptides are low molecular weight functional short peptide chains extracted from natural collagen (types I/II/III) through enzymatic hydrolysis or biotechnology, retaining specific bioactive sequences and possessing high absorption rates and targeted physiological regulatory functions.

United States market for Active Collagen Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Active Collagen Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Active Collagen Peptide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Active Collagen Peptide players cover Meiji, PB Leiner, GELITA, Amicogen, Rousselot, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Active Collagen Peptide Industry Forecast” looks at past sales and reviews total world Active Collagen Peptide sales in 2024, providing a comprehensive analysis by region and market sector of projected Active Collagen Peptide sales for 2025 through 2031. With Active Collagen Peptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Collagen Peptide industry.

This Insight Report provides a comprehensive analysis of the global Active Collagen Peptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Collagen Peptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Active Collagen Peptide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Collagen Peptide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Collagen Peptide.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Collagen Peptide market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Animal Source

    Recombinant Human Source

Segmentation by Application:

    Pharmaceuticals

    Medical Beauty and Skin Management

    Functional Foods

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Meiji

    PB Leiner

    GELITA

    Amicogen

    Rousselot

    Hubei Reborn Biological Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Active Collagen Peptide market?

What factors are driving Active Collagen Peptide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Active Collagen Peptide market opportunities vary by end market size?

How does Active Collagen Peptide break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Active Collagen Peptide Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Active Collagen Peptide by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Active Collagen Peptide by Country/Region, 2020, 2024 & 2031
    2.2 Active Collagen Peptide Segment by Type
        2.2.1 Animal Source
        2.2.2 Recombinant Human Source
    2.3 Active Collagen Peptide Sales by Type
        2.3.1 Global Active Collagen Peptide Sales Market Share by Type (2020-2025)
        2.3.2 Global Active Collagen Peptide Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Active Collagen Peptide Sale Price by Type (2020-2025)
    2.4 Active Collagen Peptide Segment by Application
        2.4.1 Pharmaceuticals
        2.4.2 Medical Beauty and Skin Management
        2.4.3 Functional Foods
    2.5 Active Collagen Peptide Sales by Application
        2.5.1 Global Active Collagen Peptide Sale Market Share by Application (2020-2025)
        2.5.2 Global Active Collagen Peptide Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Active Collagen Peptide Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Active Collagen Peptide Breakdown Data by Company
        3.1.1 Global Active Collagen Peptide Annual Sales by Company (2020-2025)
        3.1.2 Global Active Collagen Peptide Sales Market Share by Company (2020-2025)
    3.2 Global Active Collagen Peptide Annual Revenue by Company (2020-2025)
        3.2.1 Global Active Collagen Peptide Revenue by Company (2020-2025)
        3.2.2 Global Active Collagen Peptide Revenue Market Share by Company (2020-2025)
    3.3 Global Active Collagen Peptide Sale Price by Company
    3.4 Key Manufacturers Active Collagen Peptide Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Active Collagen Peptide Product Location Distribution
        3.4.2 Players Active Collagen Peptide Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Active Collagen Peptide by Geographic Region
    4.1 World Historic Active Collagen Peptide Market Size by Geographic Region (2020-2025)
        4.1.1 Global Active Collagen Peptide Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Active Collagen Peptide Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Active Collagen Peptide Market Size by Country/Region (2020-2025)
        4.2.1 Global Active Collagen Peptide Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Active Collagen Peptide Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Active Collagen Peptide Sales Growth
    4.4 APAC Active Collagen Peptide Sales Growth
    4.5 Europe Active Collagen Peptide Sales Growth
    4.6 Middle East & Africa Active Collagen Peptide Sales Growth

5 Americas
    5.1 Americas Active Collagen Peptide Sales by Country
        5.1.1 Americas Active Collagen Peptide Sales by Country (2020-2025)
        5.1.2 Americas Active Collagen Peptide Revenue by Country (2020-2025)
    5.2 Americas Active Collagen Peptide Sales by Type (2020-2025)
    5.3 Americas Active Collagen Peptide Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Active Collagen Peptide Sales by Region
        6.1.1 APAC Active Collagen Peptide Sales by Region (2020-2025)
        6.1.2 APAC Active Collagen Peptide Revenue by Region (2020-2025)
    6.2 APAC Active Collagen Peptide Sales by Type (2020-2025)
    6.3 APAC Active Collagen Peptide Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Active Collagen Peptide by Country
        7.1.1 Europe Active Collagen Peptide Sales by Country (2020-2025)
        7.1.2 Europe Active Collagen Peptide Revenue by Country (2020-2025)
    7.2 Europe Active Collagen Peptide Sales by Type (2020-2025)
    7.3 Europe Active Collagen Peptide Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Active Collagen Peptide by Country
        8.1.1 Middle East & Africa Active Collagen Peptide Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Active Collagen Peptide Revenue by Country (2020-2025)
    8.2 Middle East & Africa Active Collagen Peptide Sales by Type (2020-2025)
    8.3 Middle East & Africa Active Collagen Peptide Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Active Collagen Peptide
    10.3 Manufacturing Process Analysis of Active Collagen Peptide
    10.4 Industry Chain Structure of Active Collagen Peptide

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Active Collagen Peptide Distributors
    11.3 Active Collagen Peptide Customer

12 World Forecast Review for Active Collagen Peptide by Geographic Region
    12.1 Global Active Collagen Peptide Market Size Forecast by Region
        12.1.1 Global Active Collagen Peptide Forecast by Region (2026-2031)
        12.1.2 Global Active Collagen Peptide Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Active Collagen Peptide Forecast by Type (2026-2031)
    12.7 Global Active Collagen Peptide Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Meiji
        13.1.1 Meiji Company Information
        13.1.2 Meiji Active Collagen Peptide Product Portfolios and Specifications
        13.1.3 Meiji Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Meiji Main Business Overview
        13.1.5 Meiji Latest Developments
    13.2 PB Leiner
        13.2.1 PB Leiner Company Information
        13.2.2 PB Leiner Active Collagen Peptide Product Portfolios and Specifications
        13.2.3 PB Leiner Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 PB Leiner Main Business Overview
        13.2.5 PB Leiner Latest Developments
    13.3 GELITA
        13.3.1 GELITA Company Information
        13.3.2 GELITA Active Collagen Peptide Product Portfolios and Specifications
        13.3.3 GELITA Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 GELITA Main Business Overview
        13.3.5 GELITA Latest Developments
    13.4 Amicogen
        13.4.1 Amicogen Company Information
        13.4.2 Amicogen Active Collagen Peptide Product Portfolios and Specifications
        13.4.3 Amicogen Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Amicogen Main Business Overview
        13.4.5 Amicogen Latest Developments
    13.5 Rousselot
        13.5.1 Rousselot Company Information
        13.5.2 Rousselot Active Collagen Peptide Product Portfolios and Specifications
        13.5.3 Rousselot Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Rousselot Main Business Overview
        13.5.5 Rousselot Latest Developments
    13.6 Hubei Reborn Biological Technology
        13.6.1 Hubei Reborn Biological Technology Company Information
        13.6.2 Hubei Reborn Biological Technology Active Collagen Peptide Product Portfolios and Specifications
        13.6.3 Hubei Reborn Biological Technology Active Collagen Peptide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Hubei Reborn Biological Technology Main Business Overview
        13.6.5 Hubei Reborn Biological Technology Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Active Collagen Peptide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Active Collagen Peptide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Animal Source
 Table 4. Major Players of Recombinant Human Source
 Table 5. Global Active Collagen Peptide Sales by Type (2020-2025) & (K Units)
 Table 6. Global Active Collagen Peptide Sales Market Share by Type (2020-2025)
 Table 7. Global Active Collagen Peptide Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Active Collagen Peptide Revenue Market Share by Type (2020-2025)
 Table 9. Global Active Collagen Peptide Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Active Collagen Peptide Sale by Application (2020-2025) & (K Units)
 Table 11. Global Active Collagen Peptide Sale Market Share by Application (2020-2025)
 Table 12. Global Active Collagen Peptide Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Active Collagen Peptide Revenue Market Share by Application (2020-2025)
 Table 14. Global Active Collagen Peptide Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Active Collagen Peptide Sales by Company (2020-2025) & (K Units)
 Table 16. Global Active Collagen Peptide Sales Market Share by Company (2020-2025)
 Table 17. Global Active Collagen Peptide Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Active Collagen Peptide Revenue Market Share by Company (2020-2025)
 Table 19. Global Active Collagen Peptide Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Active Collagen Peptide Producing Area Distribution and Sales Area
 Table 21. Players Active Collagen Peptide Products Offered
 Table 22. Active Collagen Peptide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Active Collagen Peptide Sales by Geographic Region (2020-2025) & (K Units)
 Table 26. Global Active Collagen Peptide Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Active Collagen Peptide Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Active Collagen Peptide Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Active Collagen Peptide Sales by Country/Region (2020-2025) & (K Units)
 Table 30. Global Active Collagen Peptide Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Active Collagen Peptide Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Active Collagen Peptide Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Active Collagen Peptide Sales by Country (2020-2025) & (K Units)
 Table 34. Americas Active Collagen Peptide Sales Market Share by Country (2020-2025)
 Table 35. Americas Active Collagen Peptide Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Active Collagen Peptide Sales by Type (2020-2025) & (K Units)
 Table 37. Americas Active Collagen Peptide Sales by Application (2020-2025) & (K Units)
 Table 38. APAC Active Collagen Peptide Sales by Region (2020-2025) & (K Units)
 Table 39. APAC Active Collagen Peptide Sales Market Share by Region (2020-2025)
 Table 40. APAC Active Collagen Peptide Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Active Collagen Peptide Sales by Type (2020-2025) & (K Units)
 Table 42. APAC Active Collagen Peptide Sales by Application (2020-2025) & (K Units)
 Table 43. Europe Active Collagen Peptide Sales by Country (2020-2025) & (K Units)
 Table 44. Europe Active Collagen Peptide Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Active Collagen Peptide Sales by Type (2020-2025) & (K Units)
 Table 46. Europe Active Collagen Peptide Sales by Application (2020-2025) & (K Units)
 Table 47. Middle East & Africa Active Collagen Peptide Sales by Country (2020-2025) & (K Units)
 Table 48. Middle East & Africa Active Collagen Peptide Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Active Collagen Peptide Sales by Type (2020-2025) & (K Units)
 Table 50. Middle East & Africa Active Collagen Peptide Sales by Application (2020-2025) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Active Collagen Peptide
 Table 52. Key Market Challenges & Risks of Active Collagen Peptide
 Table 53. Key Industry Trends of Active Collagen Peptide
 Table 54. Active Collagen Peptide Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Active Collagen Peptide Distributors List
 Table 57. Active Collagen Peptide Customer List
 Table 58. Global Active Collagen Peptide Sales Forecast by Region (2026-2031) & (K Units)
 Table 59. Global Active Collagen Peptide Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Active Collagen Peptide Sales Forecast by Country (2026-2031) & (K Units)
 Table 61. Americas Active Collagen Peptide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Active Collagen Peptide Sales Forecast by Region (2026-2031) & (K Units)
 Table 63. APAC Active Collagen Peptide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Active Collagen Peptide Sales Forecast by Country (2026-2031) & (K Units)
 Table 65. Europe Active Collagen Peptide Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Active Collagen Peptide Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Middle East & Africa Active Collagen Peptide Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Active Collagen Peptide Sales Forecast by Type (2026-2031) & (K Units)
 Table 69. Global Active Collagen Peptide Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Active Collagen Peptide Sales Forecast by Application (2026-2031) & (K Units)
 Table 71. Global Active Collagen Peptide Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Meiji Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 73. Meiji Active Collagen Peptide Product Portfolios and Specifications
 Table 74. Meiji Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Meiji Main Business
 Table 76. Meiji Latest Developments
 Table 77. PB Leiner Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 78. PB Leiner Active Collagen Peptide Product Portfolios and Specifications
 Table 79. PB Leiner Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. PB Leiner Main Business
 Table 81. PB Leiner Latest Developments
 Table 82. GELITA Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 83. GELITA Active Collagen Peptide Product Portfolios and Specifications
 Table 84. GELITA Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. GELITA Main Business
 Table 86. GELITA Latest Developments
 Table 87. Amicogen Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 88. Amicogen Active Collagen Peptide Product Portfolios and Specifications
 Table 89. Amicogen Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Amicogen Main Business
 Table 91. Amicogen Latest Developments
 Table 92. Rousselot Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 93. Rousselot Active Collagen Peptide Product Portfolios and Specifications
 Table 94. Rousselot Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Rousselot Main Business
 Table 96. Rousselot Latest Developments
 Table 97. Hubei Reborn Biological Technology Basic Information, Active Collagen Peptide Manufacturing Base, Sales Area and Its Competitors
 Table 98. Hubei Reborn Biological Technology Active Collagen Peptide Product Portfolios and Specifications
 Table 99. Hubei Reborn Biological Technology Active Collagen Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Hubei Reborn Biological Technology Main Business
 Table 101. Hubei Reborn Biological Technology Latest Developments


List of Figures
 Figure 1. Picture of Active Collagen Peptide
 Figure 2. Active Collagen Peptide Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Active Collagen Peptide Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Active Collagen Peptide Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Active Collagen Peptide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Active Collagen Peptide Sales Market Share by Country/Region (2024)
 Figure 10. Active Collagen Peptide Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Animal Source
 Figure 12. Product Picture of Recombinant Human Source
 Figure 13. Global Active Collagen Peptide Sales Market Share by Type in 2025
 Figure 14. Global Active Collagen Peptide Revenue Market Share by Type (2020-2025)
 Figure 15. Active Collagen Peptide Consumed in Pharmaceuticals
 Figure 16. Global Active Collagen Peptide Market: Pharmaceuticals (2020-2025) & (K Units)
 Figure 17. Active Collagen Peptide Consumed in Medical Beauty and Skin Management
 Figure 18. Global Active Collagen Peptide Market: Medical Beauty and Skin Management (2020-2025) & (K Units)
 Figure 19. Active Collagen Peptide Consumed in Functional Foods
 Figure 20. Global Active Collagen Peptide Market: Functional Foods (2020-2025) & (K Units)
 Figure 21. Global Active Collagen Peptide Sale Market Share by Application (2024)
 Figure 22. Global Active Collagen Peptide Revenue Market Share by Application in 2025
 Figure 23. Active Collagen Peptide Sales by Company in 2025 (K Units)
 Figure 24. Global Active Collagen Peptide Sales Market Share by Company in 2025
 Figure 25. Active Collagen Peptide Revenue by Company in 2025 ($ millions)
 Figure 26. Global Active Collagen Peptide Revenue Market Share by Company in 2025
 Figure 27. Global Active Collagen Peptide Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Active Collagen Peptide Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Active Collagen Peptide Sales 2020-2025 (K Units)
 Figure 30. Americas Active Collagen Peptide Revenue 2020-2025 ($ millions)
 Figure 31. APAC Active Collagen Peptide Sales 2020-2025 (K Units)
 Figure 32. APAC Active Collagen Peptide Revenue 2020-2025 ($ millions)
 Figure 33. Europe Active Collagen Peptide Sales 2020-2025 (K Units)
 Figure 34. Europe Active Collagen Peptide Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Active Collagen Peptide Sales 2020-2025 (K Units)
 Figure 36. Middle East & Africa Active Collagen Peptide Revenue 2020-2025 ($ millions)
 Figure 37. Americas Active Collagen Peptide Sales Market Share by Country in 2025
 Figure 38. Americas Active Collagen Peptide Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Active Collagen Peptide Sales Market Share by Type (2020-2025)
 Figure 40. Americas Active Collagen Peptide Sales Market Share by Application (2020-2025)
 Figure 41. United States Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Active Collagen Peptide Sales Market Share by Region in 2025
 Figure 46. APAC Active Collagen Peptide Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Active Collagen Peptide Sales Market Share by Type (2020-2025)
 Figure 48. APAC Active Collagen Peptide Sales Market Share by Application (2020-2025)
 Figure 49. China Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Active Collagen Peptide Sales Market Share by Country in 2025
 Figure 57. Europe Active Collagen Peptide Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Active Collagen Peptide Sales Market Share by Type (2020-2025)
 Figure 59. Europe Active Collagen Peptide Sales Market Share by Application (2020-2025)
 Figure 60. Germany Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Active Collagen Peptide Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Active Collagen Peptide Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Active Collagen Peptide Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Active Collagen Peptide Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Active Collagen Peptide in 2025
 Figure 74. Manufacturing Process Analysis of Active Collagen Peptide
 Figure 75. Industry Chain Structure of Active Collagen Peptide
 Figure 76. Channels of Distribution
 Figure 77. Global Active Collagen Peptide Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Active Collagen Peptide Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Active Collagen Peptide Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Active Collagen Peptide Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Active Collagen Peptide Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Active Collagen Peptide Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Meiji

PB Leiner

GELITA

Amicogen

Rousselot

Hubei Reborn Biological Technology

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff